MedTrace Logo

Use of Methylphenidate in Children and Adolescents in France

NCT03371069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2017-12-13

No results posted yet for this study

Summary

The use of methylphenidate in children and adolescents in France from 2010 to 2015

Conditions

  • Use of Methylphenidate in Children and Adolescents

Interventions

OTHER

users of methylphenidate

Children and adolescents who are users of methylphenidate, 2010 to 2015

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Florentia Kaguelidou, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03371069 on ClinicalTrials.gov